retatrutide trial news today Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Trial of next-gen weight-loss drug

CrossRef Feasibility of terahertz reflectometry for discrimination of human early gastric cancers Young Bin Ji, Chan Hyuk Park, Hyunki Kim, Sang-Hoon Kim, Gyu Min Lee, Sam Kyu Noh, Tae-In Jeon, Joo-Hiuk Son, Yong-Min Huh, Seungjoo Haam, Seung Jae Oh, Sang Kil Lee, Jin-Suck Suh Biomedical Optics Express.2015

Aliquam feugiat dapibus nunc, sit amet aliquam metus sollicitudin eget

Explore Alternative Applications Highlights Product Details Shipping Exclusions

In clinical trials of Wegovy, alopecia was reported in about 3% of adult patients on the medication versus 1% on placebo

Watch: GLP-1 hair loss explained This short medical explainer covers the likely cause, the usual shedding timeline, and the practical next steps if your hair starts thinning on a GLP-1